Intranasal neostigmine vs placebo
Change in impairment 1 to 14 days after the start of treatment ‐ not reported · people with myasthenia gravis
The review found no eligible studies for this question.
1 finding from 1 review
- Acetylcholinesterase inhibitor treatment for myasthenia gravis 2014 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found